In the last trading session, 1.57 million Inhibikase Therapeutics Inc (NASDAQ:IKT) shares changed hands as the company’s beta touched 1.15. With the company’s per share
In recent trading session, Inhibikase Therapeutics Inc (NASDAQ:IKT) saw 0.9 million shares changing hands at last check today with its beta currently measuring 1.15. Company’s
During the last session, Inhibikase Therapeutics Inc (NASDAQ:IKT)’s traded shares were 19.38 million, with the beta value of the company hitting 1.33. At the end
In today’s recent session, 14.43 million shares of the Inhibikase Therapeutics Inc (NASDAQ:IKT) have been traded, and its beta is 1.33. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
